Vitamin D as an effective treatment in human uterine leiomyomas independent of mediator complex subunit 12 mutation

Vitamin D inhibits cell proliferation and extracellular matrix formation through inhibition of Wnt/b-catenin and transforming growth factor b pathways in human uterine leiomyoma primary cells independent of mediator complex subunit 12 mutation status.

Like Comment
Related Content

VOLUME 115, ISSUE 2, P512-521

Authors:

Ana Corachán, Ph.D., María Gabriela Trejo, M.Sc., María Cristina Carbajo-García, M.Sc., Javier Monleón, M.D., Julia Escrig, M.D., Amparo Faus, B.Sc., Antonio Pellicer, M.D., Irene Cervelló, Ph.D., Hortensia Ferrero, Ph.D. 

Abstract:

Objective

To study whether vitamin D (VitD) inhibits cell proliferation and Wnt/β-catenin and transforming growth factor−β (TGFβ) signaling pathways in uterine leiomyomas independent of mediator complex subunit 12 (MED12) mutation status.


Design

Prospective study comparing leiomyoma vs. myometrial tissues and human uterine leiomyoma primary (HULP) cells treated with or without VitD and analyzed by MED12 mutation status.


Setting

Hospital and university laboratories.


Patient(s)

Women with uterine leiomyoma without any treatment (n = 37).


Intervention(s)

Uterine leiomyoma and myometrium samples were collected from women undergoing surgery because of symptomatic leiomyoma pathology.


Main Outcome Measure(s)

Analysis of Wnt/β-catenin and TGFβ pathways and proliferation by quantitative real-time polymerase chain reaction in leiomyoma and myometrial tissue as well as in VitD-treated HULP cells analyzed by Sanger sequencing.


Results

Sequencing data showed that 46% of leiomyomas presented MED12 mutation, whereas no mutations were detected in adjacent myometrium. Expression of Wnt/β-catenin and TGFβ pathway genes was significantly increased in MED12-mutated leiomyomas compared to matched myometrium; no significant differences were found in wild-type (WT) leiomyomas. In HULP cells, VitD significantly decreased PCNA expression of both MED12-mutated and WT groups. VitD treatment decreased WNT4 and β-catenin expression in both groups compared to controls, with significance for WNT4 expression in MED12-mutated samples. Similarly, VitD significantly inhibited TGFβ3 expression in cells from both groups. MMP9 expression also decreased.


Conclusion

Despite molecular differences between MED12-mutated and WT leiomyomas, VitD inhibited Wnt/β-catenin and TGFβ pathways in HULP cells, suggesting VitD as an effective treatment to reduce proliferation and extracellular matrix formation in different molecular subtypes of uterine leiomyomas.

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.